Pre-visit video only group for Attention Deficit Hyperactivity Disorder (ADHD)

University of North Carolina at Chapel Hill, Chapel Hill, NC
Attention Deficit Hyperactivity Disorder (ADHD)Pre-visit video - Behavioral
Eligibility
11 - 17
All Sexes
What conditions do you have?
Select

Study Summary

This trial will evaluate the feasibility of using a video and/or question prompt lists to improve communication about ADHD in 11-17 year-olds and their families.

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 6 months

6 months
Vanderbilt Assessment Total Symptom Score (parent informant)
Youth functioning using the Vanderbilt Assessment (parent informant) Average Performance Score

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

4 Treatment Groups

Control group
1 of 4
Pre-visit video only group
1 of 4
Question prompt list only group
1 of 4
Combined question prompt list/video intervention group
1 of 4

Active Control

Experimental Treatment

140 Total Participants · 4 Treatment Groups

Primary Treatment: Pre-visit video only group · No Placebo Group · N/A

Pre-visit video only group
Behavioral
Experimental Group · 1 Intervention: Pre-visit video · Intervention Types: Behavioral
Question prompt list only group
Behavioral
Experimental Group · 1 Intervention: Question prompt list · Intervention Types: Behavioral
Combined question prompt list/video intervention groupExperimental Group · 3 Interventions: Pre-visit video, Combined question prompt list/video, Question prompt list · Intervention Types: Behavioral, Behavioral, Behavioral
Control groupNoIntervention Group · 1 Intervention: Control group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,616 Previous Clinical Trials
1,982,787 Total Patients Enrolled
93 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
19,984 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
University of North Carolina, Chapel HillLead Sponsor
1,396 Previous Clinical Trials
3,743,734 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
58 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Betsy Sleath, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
1 Previous Clinical Trials
380 Total Patients Enrolled

Eligibility Criteria

Age 11 - 17 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is this medical experiment open to individuals younger than fifty-five?

"This trial is open to young adults aged 11-17. Of all the clinical trials available, 103 are specifically designed for participants under 18 and 27 have been created with seniors in mind." - Anonymous Online Contributor

Unverified Answer

Who would benefit from participating in this clinical trial?

"To be part of this clinical trial, participants must possess a diagnosis of ADHD and range between 11 to 17 years old. Around 140 individuals are being recruited for the experiment." - Anonymous Online Contributor

Unverified Answer

What is the cumulative sample size of participants involved in this trial?

"Affirmative, the information on clinicaltrials.gov reveals this trial is actively enrolling participants. It was initially published on March 22nd 2023 and modified most recently on April 18th of the same year. This study aims to recruit 140 volunteers from one medical centre." - Anonymous Online Contributor

Unverified Answer

Are there still vacancies for participants of this clinical investigation?

"Clinicaltrials.gov confirms that this trial is currently recruiting participants, with the research first posted on March 22nd 2023 and last updated April 18th of the same year." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.